• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染期间体液中内毒素结合蛋白的相对浓度。

Relative concentrations of endotoxin-binding proteins in body fluids during infection.

作者信息

Opal S M, Palardy J E, Marra M N, Fisher C J, McKelligon B M, Scott R W

机构信息

Infectious Disease Division, Memorial Hospital, Providence, Rhode Island.

出版信息

Lancet. 1994 Aug 13;344(8920):429-31. doi: 10.1016/s0140-6736(94)91767-1.

DOI:10.1016/s0140-6736(94)91767-1
PMID:7520106
Abstract

Endotoxin initiates the systemic inflammatory response, haemodynamic changes, and multi-organ failure that may occur as a consequence of systemic gram-negative bacterial infection. The serum protein lipopolysaccharide-binding protein (LBP) binds to the lipid A component of bacterial endotoxin and facilitates its delivery to the CD14 antigen on the macrophage, where inflammatory cytokines are released and a cascade of host mediators is initiated. The neutrophil granular protein bactericidal/permeability-increasing protein (BPI) competes with LBP for endotoxin binding and functions as a molecular antagonist of LBP-endotoxin interactions. We have measured concentrations of both proteins in body fluids from 49 consecutive patients. In 16 of 17 samples of fluid from closed-space infections, BPI was present in greater concentration than LBP (median BPI/LBP ratio 7.6 [95% CI 2.32-22.1]). The ratio of BPI and LBP was not significantly different from 1.0 in abdominal fluid from 10 patients with peritonitis (ratio 0.235 [0.18-0.47]), whereas the BPI/LBP ratio was low in 22 non-infected body fluids (0.01 [0.001-0.04]) and concentrations of both proteins approached those in normal human plasma. BPI concentrations were directly correlated with the quantity of neutrophils within clinical samples (rs = 0.81, p < 0.0001). Thus, within abscess cavities BPI is available in sufficient quantities for effective competition with LBP for endotoxin. BPI may attenuate the local inflammatory response and the systemic toxicity of endotoxin release during gram-negative infections.

摘要

内毒素可引发全身炎症反应、血流动力学变化以及多器官功能衰竭,这些情况可能是全身性革兰氏阴性菌感染的后果。血清蛋白脂多糖结合蛋白(LBP)与细菌内毒素的脂质A成分结合,并促进其传递至巨噬细胞上的CD14抗原,在那里会释放炎性细胞因子并启动一系列宿主介质。中性粒细胞颗粒蛋白杀菌/通透性增加蛋白(BPI)与LBP竞争内毒素结合,并作为LBP - 内毒素相互作用的分子拮抗剂发挥作用。我们测量了49例连续患者体液中这两种蛋白的浓度。在17份来自密闭空间感染的体液样本中的16份中,BPI的浓度高于LBP(BPI/LBP比值中位数为7.6 [95%可信区间2.32 - 22.1])。10例腹膜炎患者腹腔液中BPI和LBP的比值与1.0无显著差异(比值为0.235 [0.18 - 0.47]),而在22份未感染的体液中BPI/LBP比值较低(0.01 [0.001 - 0.04]),且两种蛋白的浓度接近正常人血浆中的浓度。BPI浓度与临床样本中的中性粒细胞数量直接相关(rs = 0.81,p < 0.0001)。因此,在脓肿腔内,BPI有足够的量与LBP有效竞争内毒素。BPI可能会减轻革兰氏阴性菌感染期间局部炎症反应和内毒素释放的全身毒性。

相似文献

1
Relative concentrations of endotoxin-binding proteins in body fluids during infection.感染期间体液中内毒素结合蛋白的相对浓度。
Lancet. 1994 Aug 13;344(8920):429-31. doi: 10.1016/s0140-6736(94)91767-1.
2
Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis.内毒素血症或脓毒症期间多形核白细胞表面及血浆杀菌/通透性增加蛋白和血浆脂多糖结合蛋白的变化
Arch Surg. 1994 Feb;129(2):220-6. doi: 10.1001/archsurg.1994.01420260116016.
3
Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria.杀菌/通透性增加蛋白(BPI)和脂多糖结合蛋白(LBP):宿主抵御革兰氏阴性菌的结构、功能及调节
Biochem Soc Trans. 2003 Aug;31(Pt 4):785-90. doi: 10.1042/bst0310785.
4
Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients.慢性肾衰竭及血液透析患者的血浆脂多糖结合蛋白和杀菌/通透性增加蛋白
J Am Soc Nephrol. 1996 Mar;7(3):479-87. doi: 10.1681/ASN.V73479.
5
Lipopolysaccharide-binding protein and bactericidal/permeability-increasing factor during hemodialysis: clinical determinants and role of different membranes.血液透析过程中的脂多糖结合蛋白和杀菌/通透性增加因子:临床决定因素及不同膜的作用
J Am Soc Nephrol. 1997 Mar;8(3):463-70. doi: 10.1681/ASN.V83463.
6
Measurement of bactericidal/permeability-increasing protein in human body fluids by sandwich ELISA.采用夹心酶联免疫吸附测定法检测人体体液中的杀菌/通透性增加蛋白。
J Immunol Methods. 1994 Jan 3;167(1-2):227-35. doi: 10.1016/0022-1759(94)90091-4.
7
The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.杀菌/通透性增加蛋白作为细菌内毒素天然抑制剂的作用。
J Immunol. 1992 Jan 15;148(2):532-7.
8
Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis.血液透析期间血浆杀菌/通透性增加蛋白(BPI)和脂多糖结合蛋白(LBP)的水平
Clin Nephrol. 1993 Dec;40(6):346-51.
9
Lipopolysaccharide toxicity-regulating proteins in bacteremia.菌血症中脂多糖毒性调节蛋白
J Infect Dis. 1995 May;171(5):1250-7. doi: 10.1093/infdis/171.5.1250.
10
Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.脂多糖结合蛋白与杀菌/通透性增加蛋白对脂多糖诱导单核吞噬细胞释放细胞因子的拮抗作用。对脂多糖结合的竞争。
J Immunol. 1993 Oct 15;151(8):4258-65.

引用本文的文献

1
Lipopolysaccharide-binding protein and future Parkinson's disease risk: a European prospective cohort.脂多糖结合蛋白与未来帕金森病风险:一项欧洲前瞻性队列研究。
J Neuroinflammation. 2023 Jul 21;20(1):170. doi: 10.1186/s12974-023-02846-2.
2
Salivary bactericidal/permeability-increasing protein: A novel inflammatory marker associated with periodontitis.唾液杀菌/通透性增加蛋白:与牙周炎相关的新型炎症标志物。
Clin Oral Investig. 2023 Jun;27(6):3159-3167. doi: 10.1007/s00784-023-04922-6. Epub 2023 Feb 20.
3
Balancing Innate Immunity and Inflammatory State via Modulation of Neutrophil Function: A Novel Strategy to Fight Sepsis.
通过调节中性粒细胞功能来平衡先天免疫和炎症状态:一种抗击败血症的新策略。
J Immunol Res. 2015;2015:187048. doi: 10.1155/2015/187048. Epub 2015 Dec 21.
4
Antimicrobial Peptides in Human Sepsis.人类脓毒症中的抗菌肽
Front Immunol. 2015 Aug 20;6:404. doi: 10.3389/fimmu.2015.00404. eCollection 2015.
5
Repeated oronasal exposure to lipopolysaccharide induced mucosal IgA responses in periparturient dairy cows.围产期奶牛经口鼻腔反复暴露于脂多糖可诱导黏膜IgA反应。
PLoS One. 2014 Jul 25;9(7):e103504. doi: 10.1371/journal.pone.0103504. eCollection 2014.
6
Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect.迈向抗内毒素抗体的临床应用;重新评估脱节之处。
Toxins (Basel). 2013 Dec 18;5(12):2589-620. doi: 10.3390/toxins5122589.
7
Identification of single nucleotide polymorphisms in hematopoietic cell transplant patients affecting early recognition of, and response to, endotoxin.造血细胞移植患者中影响对内毒素早期识别及反应的单核苷酸多态性的鉴定。
Innate Immun. 2014 Oct;20(7):697-711. doi: 10.1177/1753425913505122. Epub 2013 Oct 9.
8
The anti-inflammatory effect of the synthetic antimicrobial peptide 19-2.5 in a murine sepsis model: a prospective randomized study.合成抗菌肽19-2.5在小鼠脓毒症模型中的抗炎作用:一项前瞻性随机研究。
Crit Care. 2013 Jan 9;17(1):R3. doi: 10.1186/cc11920.
9
Antimicrobial peptides and their potential application in inflammation and sepsis.抗菌肽及其在炎症和脓毒症中的潜在应用。
Crit Care. 2012 Dec 12;16(2):207. doi: 10.1186/cc11220.
10
Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials.弯曲杆菌荚膜和脂寡糖赋予其对血清和阳离子抗菌药物的抗性。
Virulence. 2011 Jan-Feb;2(1):30-40. doi: 10.4161/viru.2.1.14752. Epub 2011 Jan 1.